Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronabinol for Postoperative Pain After Arthroscopic Knee Surgery
NCT05335252Phase 3Active, not recruiting
- Sponsor
- Northwestern University
- Start
- Jun 2022
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dronabinol in postoperative pain, sponsored by Northwestern University. Started Jun 2022; status: active, not recruiting.
02
Drugs
dronabinol
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05335252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05335252.